Looking Back at 2022: Top 5 Stories About Cancer Research and Cancer Care
My picks for five of the top cancer research stories of 2022.
Exploring progress in cancer research from the patient perspective
My picks for five of the top cancer research stories of 2022.
A look at six highly rated national charities that engage primarily in cancer research.
A blood test that can detect cancer before any symptoms appear, and save lives as a result, is sometimes referred to as the “holy grail” of cancer research. Are we there yet?
Cancer research stories worth following this winter include an experimental targeted therapy for metastatic triple negative breast cancer and a study on how the financial toxicity of cancer treatment affects physical health and survival.
Is the end of cancer as a deadly disease now possible? Can we actually win the war on cancer, which has been pronounced a failure by many?
What progress is being made toward a blood test or “liquid biopsy” to aid in treatment or early detection of breast cancer?
Recent research shows that external or environmental factors contribute 70 to 90 percent of the risk of cancer developing during a person’s lifetime. What does this mean for public policy?
Taking a look back at major stories about developments in cancer research and breast cancer in 2015.
Research findings presented at the 2015 San Antonio Breast Cancer Symposium may preview an era in which breast cancer treatments will be tailored to each patient.
What’s exciting in cancer research right now? This post reviews several of the most interesting cancer research stories that have been in the news this Fall.
After thirty years of Breast Cancer Awareness Month, actual progress against the disease has not met expectations, with over 40,000 deaths from the disease annually in the United States.
Learning to recognize the signs and symptoms of gynecologic cancers is an essential part of “awareness” during Gynecologic Cancer Awareness Month, as is advocating for appropriate levels of research funding.
Researchers are developing a vaccine to prevent breast cancer in healthy women, and hope to begin clinical trials within two years.